In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Treatment choices to optimise benefits for heart failure patients
Session

Event : Heart Failure 2019

Topic : Heart Failure with Reduced Ejection Fraction

  • Session type : Satellite Symposium
  • Date : 26 May 2019
  • Time : 14:45 - 16:00
  • Sponsored by Novartis

7 presentations in this session

Welcome video.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Sponsored by Novartis

Welcome and introduction - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Optimising treatment for patients in the vulnerable phase.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : J Butler (Atlanta,US)
  • Sponsored by Novartis

How to achieve the optimisation we aim for.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis

Personalising care for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : JJV McMurray (Glasgow,GB)
  • Sponsored by Novartis

Panel discussion - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Summary and conclusion - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : JJV McMurray (Glasgow,GB)
  • Sponsored by Novartis

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are